The European Medicines Agency (EMA) informed the company about the unauthorized access of cybercriminals to its data. The EMA possessed the documents tied with the preliminary talks on vaccine-candidate against Covid-19 developed by Moderna Inc. This information was promising for perpetrators and they got it.
Moderna Inc. reported that the documents provided to EMA did not include information that identifies partakers of research. Currently, there is no information that any members were identified.
As we reported, as tests of various vaccine manufacturers are underway, American company Moderna, Inc. decided to shape the test group from teenagers aged from 12 to 18 years old.
Besides, it was stated that Moderna Inc. might provide immunity to the disease at least for three months.